Free Trial

Cyclerion Therapeutics (CYCN) Short Interest Ratio & Short Volume

Cyclerion Therapeutics logo
$2.95
+0.06 (+2.08%)
(As of 11/1/2024 ET)

Cyclerion Therapeutics Short Interest Data

Cyclerion Therapeutics (CYCN) has a short interest of 12,000 shares, representing 0.58% of the float (the number of shares available for trading by the public). This marks a 11.11% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 6,589 shares to cover all short positions.

Current Short Interest
12,000 shares
Previous Short Interest
10,800 shares
Change Vs. Previous Month
+11.11%
Dollar Volume Sold Short
$29,160.00
Short Interest Ratio
1.9 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
2,710,000 shares
Float Size
2,080,000 shares
Short Percent of Float
0.58%
Today's Trading Volume
125,048 shares
Average Trading Volume
6,589 shares
Today's Volume Vs. Average
1,898%
Short Selling Cyclerion Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Cyclerion Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CYCN Short Interest Over Time

CYCN Days to Cover Over Time

CYCN Percentage of Float Shorted Over Time

Cyclerion Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/202412,000 shares $29,160.00 +11.1%0.6%1.9 $2.43
9/30/202410,800 shares $27,864.00 -17.6%0.5%1.8 $2.58
9/15/202413,100 shares $37,990.00 No Change0.6%2.3 $2.90
8/31/202413,100 shares $38,383.00 -3.0%0.6%2 $2.93
8/15/202413,500 shares $37,260.00 -18.2%0.7%2.2 $2.76
7/31/202416,500 shares $60,060.00 -4.6%0.8%2.8 $3.64
7/15/202417,300 shares $50,516.00 +10.9%0.8%3.6 $2.92
6/30/202415,600 shares $35,880.00 +7.6%0.8%3.9 $2.30
6/15/202414,500 shares $39,376.20 -18.5%0.7%4.5 $2.72
5/31/202417,800 shares $47,526.00 -4.3%0.9%8.9 $2.67
5/15/202418,600 shares $55,428.00 -4.1%0.9%8.1 $2.98
4/30/202419,400 shares $56,454.00 -4.0%1.0%7.2 $2.91
4/15/202420,200 shares $69,488.00 -8.6%1.0%7 $3.44
3/31/202422,100 shares $70,720.00 -6.0%1.2%7.4 $3.20
3/15/202423,500 shares $76,375.00 -4.9%1.3%7.8 $3.25
2/29/202424,700 shares $74,100.00 -7.8%1.3%4.2 $3.00
2/15/202426,800 shares $76,648.00 +9.8%1.6%3.6 $2.86
1/31/202424,400 shares $73,200.00 -5.8%1.4%3.1 $3.00
1/15/202425,900 shares $94,535.00 -15.1%1.5%3.4 $3.65
12/31/202330,500 shares $102,175.00 +1.0%1.7%3.5 $3.35
12/15/202330,200 shares $82,748.00 +87.6%1.7%3.5 $2.74
11/30/202316,100 shares $34,776.00 +21.1%0.9%2.2 $2.16
11/15/202313,300 shares $25,403.00 -14.2%0.7%2.1 $1.91
10/31/202315,500 shares $40,300.00 -13.9%0.8%2.2 $2.60
10/15/202318,000 shares $61,380.00 +13.2%0.9%2.1 $3.41
9/30/202315,900 shares $54,378.00 -14.5%0.8%1.8 $3.42
9/15/202318,600 shares $69,750.00 +5.7%1.0%1.8 $3.75
8/31/202317,600 shares $63,184.00 -31.8%0.8%1.6 $3.59
8/15/202325,800 shares $94,428.00 +23.4%1.2%2.1 $3.66
7/31/202320,900 shares $64,790.00 -37.8%1.0%0.7 $3.10
7/15/202333,600 shares $137,760.00 +20.0%1.6%1.1 $4.10
6/30/202328,000 shares $115,080.00 -22.7%1.2%1 $4.11
6/15/202336,200 shares $167,244.00 No Change1.7%1 $4.62
5/31/202336,200 shares $157,480.86 +168.2%1.9%1 $4.35
5/15/202313,500 shares $51,624.00 No Change0.8%0.4 $3.82
10/31/2022445,800 shares $245,190.00 +202.2%N/A2.1 $0.55
10/15/2022147,500 shares $61,404.25 -23.0%N/A0.7 $0.42
9/30/2022191,600 shares $164,776.00 -28.2%N/A1.3 $0.86
9/15/2022267,000 shares $245,613.30 +29.4%N/A1.7 $0.92
8/31/2022206,300 shares $173,292.00 +23.1%N/A0.8 $0.84
Crypto Crash Ahead? (27 Experts Weigh In) (Ad)

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.
8/15/2022167,600 shares $149,164.00 -17.6%N/A0.6 $0.89
7/31/2022203,500 shares $195,360.00 -16.7%N/A0.8 $0.96
7/15/2022244,400 shares $221,426.40 -7.7%N/A1 $0.91
6/30/2022264,700 shares $145,267.36 +4.7%N/A1.1 $0.55
6/15/2022252,800 shares $122,987.20 +12.2%N/A1 $0.49
5/31/2022225,400 shares $140,334.04 -11.5%N/A1.7 $0.62
5/15/2022254,800 shares $143,962.00 -10.8%N/A2.2 $0.57
4/30/2022285,500 shares $210,270.75 -17.4%N/A2.4 $0.74
4/15/2022345,500 shares $345,500.00 -5.8%N/A2.6 $1.00
3/31/2022366,800 shares $407,148.00 -6.9%N/A2.6 $1.11
3/15/2022393,800 shares $393,800.00 -20.1%N/A2.2 $1.00
2/28/2022492,900 shares $517,545.00 -7.9%N/A2.3 $1.05
2/15/2022535,400 shares $599,648.00 -15.6%N/A1.7 $1.12
1/31/2022634,300 shares $837,276.00 +0.7%N/A1.9 $1.32
1/15/2022629,800 shares $875,422.00 +0.8%N/A1.8 $1.39
12/31/2021624,800 shares $1.07 million -59.4%N/A1.6 $1.72
12/15/20211,540,000 shares $2.70 million -6.1%N/A3.9 $1.75
11/30/20211,640,000 shares $3.58 million +11.6%N/A3.7 $2.18
11/15/20211,470,000 shares $3.95 million +1.4%N/A3.6 $2.69
10/29/20211,450,000 shares $3.71 million +17.9%N/A4 $2.56
10/15/20211,230,000 shares $3.31 million +6.0%N/A3.1 $2.69
9/30/20211,160,000 shares $3.56 million -2.5%N/A2.4 $3.07
9/15/20211,190,000 shares $3.50 million -1.7%N/A2 $2.94
8/31/20211,210,000 shares $4.14 million -6.2%N/A1.7 $3.42
8/13/20211,290,000 shares $4.09 million -7.2%N/A1 $3.17
7/30/20211,390,000 shares $4.04 million -12.6%N/A1 $2.91
7/15/20211,590,000 shares $5.26 million -14.5%4.7%1.1 $3.31
6/30/20211,860,000 shares $7.25 million -41.5%5.5%1.4 $3.90
6/15/20213,180,000 shares $11.99 million +105.2%11.6%2.5 $3.77
5/28/20211,550,000 shares $5.02 million -11.4%5.6%1.4 $3.24
5/14/20211,750,000 shares $4.92 million +71.6%N/A3.2 $2.81
4/30/20211,020,000 shares $2.34 million +42.1%N/A1.9 $2.29
4/15/2021717,900 shares $1.97 million -6.7%N/A1 $2.75
3/31/2021769,300 shares $2.07 million +22.9%N/A1.1 $2.69
3/15/2021626,100 shares $2.67 million +14.7%N/A1 $4.27
2/26/2021546,000 shares $2.09 million -20.7%N/A0.8 $3.82
2/12/2021688,800 shares $3.09 million +12.6%N/A1 $4.49
1/29/2021611,700 shares $1.90 million +12.4%N/A0.9 $3.11
1/15/2021544,200 shares $1.86 million -6.7%N/A1.5 $3.42
12/31/2020583,000 shares $1.80 million -1.6%N/A1 $3.08
12/15/2020592,700 shares $1.94 million -3.6%N/A1 $3.27
11/30/2020614,700 shares $2.00 million -18.0%N/A1 $3.26
11/15/2020749,200 shares $2.12 million -4.1%N/A1.3 $2.83
10/30/2020781,000 shares $1.80 million -20.4%N/A1.5 $2.31
10/15/2020980,700 shares $3.29 million +4.6%N/A2 $3.35
9/30/2020937,900 shares $5.70 million +10.6%N/A3.4 $6.08
9/15/2020847,800 shares $6.35 million -7.1%N/A3 $7.49
8/31/2020913,000 shares $6.23 million -1.0%N/A3.1 $6.82
8/14/2020922,200 shares $4.79 million +9.9%N/A3.2 $5.19
7/31/2020839,500 shares $3.21 million -7.2%N/A3.1 $3.82
Crypto Crash Ahead? (27 Experts Weigh In) (Ad)

Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!

Click here to reserve your spot at the emergency crypto summit now.
7/15/2020904,600 shares $4.27 million -13.0%3.9%3.7 $4.72
6/30/20201,040,000 shares $6.15 million +26.3%4.5%4.6 $5.91
6/15/2020823,400 shares $3.80 million -16.9%3.6%3.6 $4.61
5/29/2020990,200 shares $4.00 million -15.4%4.3%4.1 $4.04
5/15/20201,170,000 shares $4.25 million -6.4%5.1%4.1 $3.63
4/30/20201,250,000 shares $4.84 million -3.9%5.4%3.5 $3.87
4/15/20201,300,000 shares $4.25 million -13.3%5.5%3.2 $3.27
3/31/20201,500,000 shares $5.42 million -28.9%6.3%2.7 $3.61
3/13/20202,110,700 shares $5.80 million +8.8%9.0%6.3 $2.75
2/28/20201,940,000 shares $6.09 million +19.8%8.3%2.6 $3.14
2/14/20201,620,000 shares $5.28 million +1.3%6.9%2.1 $3.26
1/31/20201,600,000 shares $7.04 million +17.7%6.1%1.9 $4.40
1/15/20201,360,000 shares $5.63 million +75.3%5.2%1.4 $4.14
12/31/2019776,000 shares $2.82 million +6.3%3.0%0.9 $3.64

CYCN Short Interest - Frequently Asked Questions

What is Cyclerion Therapeutics' current short interest?

Short interest is the volume of Cyclerion Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 12,000 shares of CYCN short. 0.58% of Cyclerion Therapeutics' shares are currently sold short. Learn More on Cyclerion Therapeutics' current short interest.

What is a good short interest ratio for Cyclerion Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CYCN shares currently have a short interest ratio of 2.0. Learn More on Cyclerion Therapeutics's short interest ratio.

What is a good short interest percentage for Cyclerion Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of Cyclerion Therapeutics' floating shares are currently sold short.

Is Cyclerion Therapeutics' short interest increasing or decreasing?

Cyclerion Therapeutics saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 12,000 shares, an increase of 11.1% from the previous total of 10,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cyclerion Therapeutics' float size?

Cyclerion Therapeutics currently has issued a total of 2,710,000 shares. Some of Cyclerion Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cyclerion Therapeutics currently has a public float of 2,080,000 shares.

How does Cyclerion Therapeutics' short interest compare to its competitors?

0.58% of Cyclerion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cyclerion Therapeutics: Estrella Immunopharma, Inc. (0.17%), Celularity Inc. (6.35%), Acasti Pharma Inc. (2.47%), Janone Inc. (2.05%), GlycoMimetics, Inc. (2.84%), Dyadic International, Inc. (0.86%), Acurx Pharmaceuticals, Inc. (3.63%), Enlivex Therapeutics Ltd. (0.47%), Lexaria Bioscience Corp. (1.71%), Surrozen, Inc. (1.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Cyclerion Therapeutics stock?

Short selling CYCN is an investing strategy that aims to generate trading profit from Cyclerion Therapeutics as its price is falling. CYCN shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cyclerion Therapeutics?

A short squeeze for Cyclerion Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CYCN, which in turn drives the price of the stock up even further.

How often is Cyclerion Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYCN, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:CYCN) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners